Apeloa Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of September 2025: 0.00%

Apeloa Pharmaceutical Co Ltd asset resilience ratio. Apeloa Pharmaceutical Co Ltd (000739) has an Asset Resilience Ratio of 0.00% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 000739 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥15.00K

≈ $2.20K USD Cash + Short-term Investments

Total Assets

CN¥12.10 Billion

≈ $1.77 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Apeloa Pharmaceutical Co Ltd (2010–2022)

Asset resilience ratio of Apeloa Pharmaceutical Co Ltd from 2010 to 2022. This chart shows how Apeloa Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 000739 current and long-term liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Apeloa Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 000739 asset base.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥15.00K	0.0%
Total Liquid Assets	CN¥15.00K	0.00%

Asset Resilience Insights

Limited Liquidity: Apeloa Pharmaceutical Co Ltd maintains only 0.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Apeloa Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Apeloa Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Jiangsu Nhwa Pharmaceutical Co Ltd SHE:002262	Drug Manufacturers - Specialty & Generic	26.45%
Tibet Rhodiola Pharmaceutical Holding Co SHG:600211	Drug Manufacturers - Specialty & Generic	11.84%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
Renhe Pharmacy Co Ltd SHE:000650	Drug Manufacturers - Specialty & Generic	37.54%
Bide Pharmatech Co. Ltd. A SHG:688073	Drug Manufacturers - Specialty & Generic	9.46%
Jianmin Pharmaceutical Group Co Ltd SHG:600976	Drug Manufacturers - Specialty & Generic	20.61%
Qianjiang Yongan Pharmaceutical Co Ltd SHE:002365	Drug Manufacturers - Specialty & Generic	30.38%
Shenzhen Neptunus Bioengineering Co Ltd SHE:000078	Drug Manufacturers - Specialty & Generic	0.42%

Apeloa Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2010–2022)

Apeloa Pharmaceutical Co Ltd asset resilience ratio by year from 2010 to 2022. The table below shows the annual Asset Resilience Ratio data for Apeloa Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.00%	CN¥90.11K ≈ $13.19K	CN¥12.02 Billion ≈ $1.76 Billion	-0.16pp
2021-12-31	0.16%	CN¥14.89 Million ≈ $2.18 Million	CN¥9.04 Billion ≈ $1.32 Billion	-1.39pp
2020-12-31	1.55%	CN¥116.22 Million ≈ $17.01 Million	CN¥7.49 Billion ≈ $1.10 Billion	-5.56pp
2019-12-31	7.11%	CN¥463.86 Million ≈ $67.88 Million	CN¥6.52 Billion ≈ $954.46 Million	+5.35pp
2018-12-31	1.76%	CN¥101.40 Million ≈ $14.84 Million	CN¥5.75 Billion ≈ $841.66 Million	+1.69pp
2017-12-31	0.07%	CN¥4.18 Million ≈ $611.70K	CN¥5.69 Billion ≈ $832.79 Million	+0.14pp
2016-12-31	-0.07%	CN¥-3.69 Million ≈ $-539.69K	CN¥5.62 Billion ≈ $822.23 Million	+0.01pp
2015-12-31	-0.08%	CN¥-4.15 Million ≈ $-607.01K	CN¥5.39 Billion ≈ $789.45 Million	-0.11pp
2014-12-31	0.04%	CN¥1.93 Million ≈ $281.98K	CN¥5.06 Billion ≈ $740.70 Million	0.00pp
2013-12-31	0.04%	CN¥1.98 Million ≈ $289.91K	CN¥4.66 Billion ≈ $682.23 Million	0.00pp
2012-12-31	0.05%	CN¥1.88 Million ≈ $275.17K	CN¥4.11 Billion ≈ $601.02 Million	0.00pp
2011-12-31	0.05%	CN¥1.73 Million ≈ $252.69K	CN¥3.63 Billion ≈ $530.70 Million	-0.08pp
2010-12-31	0.12%	CN¥2.29 Million ≈ $334.89K	CN¥1.84 Billion ≈ $269.92 Million	--

pp = percentage points

About Apeloa Pharmaceutical Co Ltd

SHE:000739 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.48 Billion

CN¥23.79 Billion CNY

Market Cap Rank

#4343 Global

#616 in China

Share Price

CN¥20.54

Change (1 day)

+2.19%

52-Week Range

CN¥15.09 - CN¥27.74

All Time High

CN¥39.53